Target intelligence / Profile preview

ATP-binding cassette sub-family G member 5 and member 8 (ABCG5/ABCG8)

Target
ABCG5/ABCG8
Molecular classification
Transporter, ATP-binding cassette (ABC) transporter, ABCG subfamily
01

Overview

ATP-binding cassette sub-family G member 5 and member 8 (ABCG5/ABCG8) are half-transporters that function as an obligate heterodimer to mediate the efflux of neutral sterols [1, 2]. Primarily expressed on the apical membranes of hepatocytes and enterocytes, this complex is responsible for secreting cholesterol and plant sterols (phytosterols) into bile and the intestinal lumen [2, 3]. This process is a vital component of reverse cholesterol transport and serves as a primary defense against the accumulation of dietary xenosterols [1, 4]. Mutations in either ABCG5 or ABCG8 cause sitosterolemia, a rare autosomal recessive disorder marked by elevated plant sterol levels, tendon xanthomas, and accelerated atherosclerosis [1, 3]. Additionally, common genetic variants are significantly linked to an increased risk of gallstone disease due to excessive biliary cholesterol secretion [5]. While no direct small-molecule activators are currently in clinical use, the transporter is transcriptionally regulated by nuclear receptors such as LXR and FXR, making it a key focus for research into cardiovascular and metabolic therapies [4, 5].

Other names
Sterolin-1Sterolin-2STSLSTSL1GBD4Sterolin heterodimer
02

Mechanism of action

ABCG5 and ABCG8 form an obligate heterodimer that utilizes ATP hydrolysis to actively transport neutral sterols, such as cholesterol and phytosterols, across the apical membranes of hepatocytes and enterocytes into the bile and intestinal lumen, respectively [1, 2, 3].

03

Biological functions

Sterol effluxBiliary cholesterol secretionIntestinal sterol excretionSterol homeostasisReverse cholesterol transport
04

Disease associations

SitosterolemiaGallstone diseaseCoronary artery diseaseAtherosclerosisGallbladder cancerHypercholesterolemia
05

Safety considerations

Gallstone formation (cholelithiasis) due to increased biliary cholesterolAtherosclerosis risk associated with loss-of-function variantsPhytosterol accumulation (xenosterolemia) leading to xanthomas
06

Interacting drugs

LXR agonists (e.g., T0901317, GW3965)

3 more in the full profile.

07

Biomarkers

Serum sitosterolSerum campesterolSerum cholestanolBiliary cholesterol concentrationFecal neutral sterols

Beyond the preview

Go deeper on ATP-binding cassette sub-family G member 5 and member 8 (ABCG5/ABCG8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette sub-family G member 5 and member 8 (ABCG5/ABCG8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call